| |
Males
|
Females
|
|---|
| |
<100 m
|
100-250 m
|
<100 m
|
100-250 m
|
|---|
|
Persistent wheeze
|
1.76 * (1.08-2.87)
|
1.54 # (0.94-2.53)
|
1.32 (0.76-2.28)
|
0.77 (0.42-1.42)
|
|
Dyspnea
|
0.88 (0.55-1.41)
|
0.86 (0.59-1.53)
|
1.61 ** (1.13-2.27)
|
1.35 # (0.95-1.93)
|
|
COPD
|
1.80 * (1.03-3.08)
|
1.21 (0.69-2.13)
|
1.60 (0.71-3.59)
|
0.99 (0.39-2.51)
|
|
Asthma
|
1.59 (0.85-2.98)
|
1.55 (0.83-2.87)
|
1.68 # (0.97-2.88)
|
0.58 (0.30-1.15)
|
|
Attacks of shortness of breath with wheeze
|
1.47 (0.87-2.48)
|
1.20 (0.70-2.04)
|
1.67 # (0.98-2.84)
|
0.74 (0.39-1.38)
|
|
Skin test_5 mm pos.
|
1.07 (0.67-1.72)
|
1.10 (0.70-1.73)
|
1.83 * (1.11-3.00)
|
0.95 (0.57-1.60)
|
|
FEV1/FVC% <70%
|
2.07 * (1.11-3.87)
|
2.53 ** (1.42-4.53)
|
1.01 (0.48-2.14)
|
0.88 (0.41-1.89)
|
|
FEV1/VC% <70%
|
1.15 (0.63-2.11)
|
1.76 * (1.02-3.04)
|
0.84 (0.40-1.72)
|
0.48 (0.21-1.11)
|
- † OR adjusted for age, educational level, smoking habits, passive smoking exposure, occupational exposure, working position, number of hours spent at home and time of residence, calculated with subjects living between 250-800 m as the reference group
- *** p < 0.001, ** p < 0.01, * p < 0.05, # 0.05 < p < 0.1 (borderline)
